Overview

William G. Kaelin Jr. (born November 23, 1957) is an American physician-scientist and professor of medicine affiliated with Harvard University and the Dana–Farber Cancer Institute. His laboratory focuses on how tumor suppressor proteins influence cell growth and survival. Kaelin shared the 2019 Nobel Prize in Physiology or Medicine for work that illuminated cellular mechanisms for detecting and responding to oxygen levels in tissues.

Key scientific contributions

Kaelin used cancer genetics and biochemical approaches to unravel connections between a tumor suppressor protein and oxygen-regulated factors. His studies showed how the von Hippel–Lindau (VHL) protein functions as part of a cellular machinery that targets hypoxia-inducible factors (HIFs) for degradation under normal oxygen levels. This oxygen-dependent control is mediated by chemical modification of HIF proteins, which alters their stability and activity and thereby controls the expression of genes involved in metabolism, red blood cell production and blood vessel formation.

Major findings and methods

  • Identification of VHL as a component that recognizes modified HIF proteins and directs their destruction under normoxic conditions.
  • Clarification of how proline hydroxylation of HIFs serves as an oxygen-sensitive signal for that recognition.
  • Integration of genetic studies of cancer with molecular biochemistry to link tumor suppressor dysfunction to aberrant oxygen-sensing pathways.

Impact and applications

The work for which Kaelin and his co-recipients, Peter J. Ratcliffe and Gregg L. Semenza, were honored has broad physiological and clinical relevance. Understanding the HIF pathway has opened routes toward therapies that modify oxygen responses — for example, strategies to stimulate red blood cell production in anemia, to promote tissue survival after ischemic injury, and to counteract tumor adaptations to low-oxygen environments. It also clarified the molecular basis of hereditary conditions linked to VHL mutations and certain kidney cancers where this pathway is disrupted.

Career and recognition

Kaelin's career blends basic molecular discovery with a focus on disease-relevant problems. His laboratory continues to investigate tumor suppressors and the ways cells sense stress and maintain homeostasis. The Nobel Prize highlighted the fundamental nature of oxygen sensing for health and disease and underscored how insights from cancer biology can illuminate basic cell physiology.

Notable distinctions

Beyond the Nobel recognition shared with Ratcliffe and Semenza, Kaelin's contributions are notable for connecting clinically observed tumor syndromes to molecular pathways that control gene expression in response to oxygen. This bridge between genetics, chemistry and medicine remains a prominent example of translational biomedical research.